全文获取类型
收费全文 | 82960篇 |
免费 | 8161篇 |
国内免费 | 184篇 |
专业分类
耳鼻咽喉 | 1180篇 |
儿科学 | 2493篇 |
妇产科学 | 1787篇 |
基础医学 | 11839篇 |
口腔科学 | 2022篇 |
临床医学 | 10180篇 |
内科学 | 14618篇 |
皮肤病学 | 1302篇 |
神经病学 | 6745篇 |
特种医学 | 2863篇 |
外国民族医学 | 10篇 |
外科学 | 11408篇 |
综合类 | 1681篇 |
一般理论 | 67篇 |
预防医学 | 9470篇 |
眼科学 | 1850篇 |
药学 | 6766篇 |
1篇 | |
中国医学 | 77篇 |
肿瘤学 | 4946篇 |
出版年
2021年 | 1111篇 |
2020年 | 738篇 |
2019年 | 1120篇 |
2018年 | 1394篇 |
2017年 | 1003篇 |
2016年 | 1094篇 |
2015年 | 1240篇 |
2014年 | 1631篇 |
2013年 | 2567篇 |
2012年 | 3466篇 |
2011年 | 3746篇 |
2010年 | 1986篇 |
2009年 | 1915篇 |
2008年 | 3228篇 |
2007年 | 3551篇 |
2006年 | 3415篇 |
2005年 | 3488篇 |
2004年 | 3248篇 |
2003年 | 3022篇 |
2002年 | 2961篇 |
2001年 | 2719篇 |
2000年 | 2826篇 |
1999年 | 2506篇 |
1998年 | 1083篇 |
1997年 | 896篇 |
1996年 | 880篇 |
1995年 | 783篇 |
1994年 | 823篇 |
1993年 | 756篇 |
1992年 | 2094篇 |
1991年 | 2021篇 |
1990年 | 1895篇 |
1989年 | 1872篇 |
1988年 | 1775篇 |
1987年 | 1782篇 |
1986年 | 1682篇 |
1985年 | 1672篇 |
1984年 | 1389篇 |
1983年 | 1259篇 |
1982年 | 842篇 |
1981年 | 725篇 |
1979年 | 1216篇 |
1978年 | 876篇 |
1977年 | 765篇 |
1976年 | 719篇 |
1975年 | 718篇 |
1974年 | 859篇 |
1973年 | 752篇 |
1972年 | 733篇 |
1971年 | 640篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
4.
5.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献
6.
7.
8.
9.
Nicola Flaum Emma J. Crosbie Richard J. Edmondson Miriam J. Smith Dafydd G. Evans 《Clinical genetics》2020,97(1):54-63
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately. 相似文献
10.
Evaluation of training nurses to perform semi‐automated three‐dimensional left ventricular ejection fraction using a customised workstation‐based training protocol
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)